For research use only. Not for therapeutic Use.
SJA0617(CAT: I036328) is a potent and selective inhibitor of the main protease (Mpro, also known as 3CLpro) of coronaviruses, including SARS-CoV-2. This compound is widely used in antiviral research to explore the inhibition of viral replication processes mediated by Mpro. By targeting the enzymatic activity essential for viral polyprotein processing, SJA0617 provides valuable insights into therapeutic strategies against coronavirus infections. With high specificity and excellent stability, it is a reliable tool for drug discovery and development efforts aimed at combating COVID-19 and related viral diseases.
| Catalog Number | I036328 |
| CAS Number | N/A |
| Synonyms | SJA0617; SJA 0617; SJA-0617; |
| Molecular Formula | C17H25FN2O4S |
| Purity | 98% |
| Appearance | Solid powder |
| Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
| IUPAC Name | (S)-2-((4-fluorophenyl)sulfonamido)-3-methyl-N-((S)-4-methyl-1-oxopentan-2-yl)butanamide |
| InChI | InChI=1S/C17H25FN2O4S/c1-11(2)9-14(10-21)19-17(22)16(12(3)4)20-25(23,24)15-7-5-13(18)6-8-15/h5-8,10-12,14,16,20H,9H2,1-4H3,(H,19,22)/t14-,16-/m0/s1 |
| InChIKey | WSJWUIDLGZAXID-HOCLYGCPSA-N |
| SMILES | FC1=CC=C(S(N[C@@H](C(C)C)C(N[C@@H](CC(C)C)C=O)=O)(=O)=O)C=C1 |
